skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Genome-wide screen identifies a novel prognostic signature for breast cancer survival

Journal Article · · Oncotarget
 [1];  [1];  [1];  [1];  [2];  [1]
  1. Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
  2. Univ. of California, San Francisco, CA (United States)

Large genomic datasets in combination with clinical data can be used as an unbiased tool to identify genes important in patient survival and discover potential therapeutic targets. We used a genome-wide screen to identify 587 genes significantly and robustly deregulated across four independent breast cancer (BC) datasets compared to normal breast tissue. Gene expression of 381 genes was significantly associated with relapse-free survival (RFS) in BC patients. We used a gene co-expression network approach to visualize the genetic architecture in normal breast and BCs. In normal breast tissue, co-expression cliques were identified enriched for cell cycle, gene transcription, cell adhesion, cytoskeletal organization and metabolism. In contrast, in BC, only two major co-expression cliques were identified enriched for cell cycle-related processes or blood vessel development, cell adhesion and mammary gland development processes. Interestingly, gene expression levels of 7 genes were found to be negatively correlated with many cell cycle related genes, highlighting these genes as potential tumor suppressors and novel therapeutic targets. A forward-conditional Cox regression analysis was used to identify a 12-gene signature associated with RFS. A prognostic scoring system was created based on the 12-gene signature. This scoring system robustly predicted BC patient RFS in 60 sampling test sets and was further validated in TCGA and METABRIC BC data. Our integrated study identified a 12-gene prognostic signature that could guide adjuvant therapy for BC patients and includes novel potential molecular targets for therapy.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1409428
Journal Information:
Oncotarget, Vol. 8, Issue 8; ISSN 1949-2553
Publisher:
Impact JournalsCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 16 works
Citation information provided by
Web of Science

References (58)

Complexities in the estimation of overdiagnosis in breast cancer screening journal September 2008
Multiple Pathways of TWEAK-Induced Cell Death journal January 2002
Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway journal May 2014
Quantitative proteomics study of breast cancer cell lines isolated from a single patient: Discovery of TIMM17A as a marker for breast cancer journal March 2010
Age-Specific Gene Expression Signatures for Breast Tumors and Cross-Species Conserved Potential Cancer Progression Markers in Young Women journal May 2013
Plekhh2, a novel podocyte protein downregulated in human focal segmental glomerulosclerosis, is involved in matrix adhesion and actin dynamics journal November 2012
Adjuvant therapy for breast cancer: who should get what? journal April 2001
USP47 Is a Deubiquitylating Enzyme that Regulates Base Excision Repair by Controlling Steady-State Levels of DNA Polymerase β journal March 2011
Death of HT29 adenocarcinoma cells induced by TNF family receptor activation is caspase-independent and displays features of both apoptosis and necrosis journal December 2002
Over-expression of EPS15 is a favorable prognostic factor in breast cancer journal January 2015
Identification of early molecular markers for breast cancer journal January 2011
An AMPK-Independent Signaling Pathway Downstream of the LKB1 Tumor Suppressor Controls Snail1 and Metastatic Potential journal August 2014
Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes journal July 2010
Progress in adjuvant chemotherapy for breast cancer: an overview journal August 2015
TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase journal December 2004
Lipid phosphate phosphatases: more than one way to put the brakes on LPA signaling? journal November 2014
An iron regulatory gene signature in breast cancer: more than a prognostic genetic profile? journal February 2012
WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013 journal May 2013
Heterogeneous nuclear ribonucleoprotein K upregulates the kinetochore complex component NUF2 and promotes the tumorigenicity of colon cancer cells journal March 2015
Increased Expression of the Tumor Suppressor PLZF Is a Continuous Predictor of Long-Term Survival in Malignant Melanoma Patients journal August 2008
WebGestalt: an integrated system for exploring gene sets in various biological contexts journal July 2005
Functional Expression of TWEAK and the Receptor Fn14 in Human Malignant Ovarian Tumors: Possible Implication for Ovarian Tumor Intervention journal March 2013
Subtle variations in Pten dose determine cancer susceptibility journal April 2010
The human transcriptome across tissues and individuals journal May 2015
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients journal December 2009
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells journal May 2014
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer journal September 2012
Re: Breast Cancer Incidence, 1980-2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status journal November 2007
The calcium-binding protein S100P in normal and malignant human tissues journal February 2008
Maternal Embryonic Leucine Zipper Kinase/Murine Protein Serine-Threonine Kinase 38 Is a Promising Therapeutic Target for Multiple Cancers journal November 2005
The Genotype-Tissue Expression (GTEx) project journal May 2013
Ahnak functions as a tumor suppressor via modulation of TGFβ/Smad signaling pathway journal March 2014
Hypermethylation reduces expression of tumor‐suppressor PLZF and regulates proliferation and apoptosis in non‐small‐cell lung cancers journal June 2013
Gene-expression profiling in breast cancer journal February 2005
The ubiquitin-specific protease USP47 is a novel β-TRCP interactor regulating cell survival journal December 2009
CREBRF is a potent tumor suppressor of glioblastoma by blocking hypoxia-induced autophagy via the CREB3/ATG5 pathway journal June 2016
The breast cancer genome and the complexity of different subgroups: what does it all mean? journal March 2013
Breast Cancer Incidence, 1980 2006: Combined Roles of Menopausal Hormone Therapy, Screening Mammography, and Estrogen Receptor Status journal July 2007
Prognostic and Predictive Factors in Early‐Stage Breast Cancer journal November 2004
X chromosomal abnormalities in basal-like human breast cancer journal February 2006
Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue journal March 2009
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups journal April 2012
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes journal May 2016
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes journal March 2009
Gene expression profiling predicts clinical outcome of breast cancer journal January 2002
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer journal February 2005
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer journal December 2004
Loss of PLZF Expression in Prostate Cancer by Immunohistochemistry Correlates with Tumor Aggressiveness and Metastasis journal March 2015
Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer journal August 2009
Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells journal January 2008
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes journal February 2004
High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer journal October 2010
TSC1-2 tumour suppressor and regulation of mTOR signalling: linking cell growth and proliferation? journal February 2005
Lipid phosphate phosphatase-1 expression in cancer cells attenuates tumor growth and metastasis in mice journal November 2014
Anti-IgM-induced down-regulation of nuclear Thy28 protein expression in Ramos B lymphoma cells journal January 2003
An Iron Regulatory Gene Signature Predicts Outcome in Breast Cancer journal August 2011
TWEAK can induce cell death via endogenous TNF and TNF receptor 1 journal June 1999
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1. journal May 2012

Cited By (8)

Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae journal February 2020
A 10‑microRNA prognosis scoring system in esophageal squamous cell carcinoma constructed using bioinformatic methods journal February 2018
Lipid Phosphate Phosphatases and Cancer journal September 2020
Association of FOXA1 and EMT markers (Twist1 and E-cadherin) in breast cancer journal April 2019
Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer journal August 2020
Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis journal January 2018
Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation journal March 2018
Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor‑positive/human epidermal growth factor receptor type 2 negative breast cancer journal December 2018